Ibritumomab Intravenous and Methylprednisolone Sodium Succinate Injection
Determining the interaction of Ibritumomab Intravenous and Methylprednisolone Sodium Succinate Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: methylprednisolone
Brand name: Medrol, Medrol Dosepak, MethylPREDNISolone Dose Pack, A-methapred, Depo-Medrol, Solu-Medrol
Synonyms: Methylprednisolone, MethylPREDNISolone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Methylprednisolone Tablets
- Ibritumomab Intravenous-Methyltestosterone
- Ibritumomab Intravenous-Metipranolol
- Ibritumomab Intravenous-Metipranolol Ophthalmic
- Ibritumomab Intravenous-Metoclopramide
- Ibritumomab Intravenous-Metoclopramide Hydrochloride
- Methylprednisolone Sodium Succinate Injection-Ibritumomab Tiuxetan
- Methylprednisolone Sodium Succinate Injection-Ibrutinib
- Methylprednisolone Sodium Succinate Injection-Ibrutinib Capsules
- Methylprednisolone Sodium Succinate Injection-Ibrutinib Tablets
- Methylprednisolone Sodium Succinate Injection-Ibu
- Methylprednisolone Sodium Succinate Injection-IBU Tablets